ESBL production and carbapenem resistance increased the secondary bloodstream infection rates in intensive care units in Turkey, 2014-2019
Aim: Secondary bloodstream infections (SBSIs) are caused by another infection and differ from primary bloodstream infections (PBSIs) in terms of prevention and treatment strategies. The aim of this study was to determine the risk factors for bloodstream infections which were secondary to the most co...
Saved in:
Main Authors: | Hekimoglu, Can Huseyin (Author), Yildiz, Serap Suzuk (Author), Sahan, Selda (Author), Batir, Esen (Author), Yildirim Gozel, Emine (Author), Altun, Dilek (Author), Pehlivanturk, Gulen (Author), Comce, Muhammet (Author), Kara, Fatih (Author) |
---|---|
Format: | Book |
Published: |
German Medical Science GMS Publishing House,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Carbapenem-Sparing Strategies for ESBL Producers: When and How
by: Ilias Karaiskos, et al.
Published: (2020) -
ESBL Activity, MDR, and Carbapenem Resistance among Predominant Enterobacterales Isolated in 2019
by: Altaf Bandy, et al.
Published: (2021) -
Activity of carbapenems and tigecycline against ESBL-producing Escherichia coli and Klebsiella spp.
by: Caio Fernando de Oliveira, et al.
Published: (2018) -
Risk Factors of Bloodstream Infections Caused by Carbapenem-resistant Gram-negative Pathogens in Pediatric Critical Care Settings
by: Zümrüt Şahbudak Bal, et al.
Published: (2019) -
Carbapenem alternatives for treatment of bloodstream infections due to AmpC producing enterobacterales
by: M. Ávila-Núñez, et al.
Published: (2023)